- Home
- Featured Publications
- Center Publications
- IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.
IMPAIRED AWARENESS OF HYPOGLYCEMIA CONTINUES TO BE A RISK FACTOR FOR SEVERE HYPOGLYCEMIA DESPITE THE USE OF CONTINUOUS GLUCOSE MONITORING SYSTEM IN TYPE 1 DIABETES.
Citation | “Impaired Awareness Of Hypoglycemia Continues To Be A Risk Factor For Severe Hypoglycemia Despite The Use Of Continuous Glucose Monitoring System In Type 1 Diabetes.”. Endocrine Practice : Official Journal Of The American College Of Endocrinology And The American Association Of Clinical Endocrinologists, pp. 517-525. . |
Center | Washington University in St Louis |
Author | Yu Kuei Lin, Man Hung, Anu Sharma, Owen Chan, Michael W Varner, Gitana Staskus, Simon J Fisher |
Abstract |
Impaired awareness of hypoglycemia (IAH) is a risk factor for severe hypoglycemia in patients with type 1 diabetes (T1D) not using a continuous glucose monitoring (CGM) system. The current study investigated the prevalence of IAH and its relationship with severe hypoglycemia in T1D patients using CGM systems. This cross-sectional observational study enrolled 135 patients with T1D and ongoing real-time CGM use. A survey was conducted to assess hypoglycemia awareness with the Gold, Clarke, and Pedersen-Bjergaard questionnaires and the 6-month history of severe hypoglycemia. Other diabetes histories and the CGM glucose data were collected. The Gold, Clarke, and Pedersen-Bjergaard questionnaires demonstrated the overall prevalence of IAH/abnormal awareness to be 33.3%, 43.7%, and 77.0%, respectively. Participant age and duration of T1D were consistently related to IAH or hypoglycemia unawareness with all three questionnaires (<.05). Amongst the patients using CGM for >6 months, 24.5% were found to have at least one episode of severe hypoglycemia in the preceding 6 months. IAH identified by the Gold and Clarke questionnaires and hypoglycemia unawareness identified by the Pedersen-Bjergaard questionnaire were related to 6-, 4.63-, and 5.83-fold increased risk of severe hypoglycemia ( = .001, .004, and .013), respectively. IAH identified by the Gold/Clarke questionnaires was associated with a longer duration of CGM glucose <54 mg/dL and higher glucose coefficients of variation (<.05). IAH is highly prevalent and related to a higher risk for severe hypoglycemia in T1D patients using CGM. = continuous glucose monitoring; = confidence interval; = hypoglycemia-associated autonomic failure; = hemoglobin A1C; = impaired awareness of hypoglycemia; = type 1 diabetes. |
Year of Publication |
2019
|
Journal |
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
Volume |
25
|
Issue |
6
|
Number of Pages |
517-525
|
Date Published |
06/2019
|
ISSN Number |
1530-891X
|
DOI |
10.4158/EP-2018-0527
|
Alternate Journal |
Endocr Pract
|
PMID |
30865520
|
PMCID |
PMC6771275
|
Download citation |